For the year ended December 31, 2018, the Company and its subsidiary’s revenue from sales of goods was in the amount of 333.34 million baht, increased in the amount of 76.72 million baht or 29.90% of

”) reported consolidated operating revenue of THB 264 million in Q4/2022 and THB 938 million in 2022, increased by 40% from Q4/2021 and 51% from 2021, respectively. • The increase in revenue was mainly due to

For Quarter3 of the year 2019, the administration expenses was 15.75 million baht or 15.15% from revenue compare to 13.31 million baht or 12.15% last year, increased by 2.44 million baht or 18.33

revenue from sales of products and services has increased from the previous year in the amount Baht 197.45 million, and expected in 2019 from the exist government's policy and the election that will take on

equity holders of the Company (59.7) (280.9) 221.2 78.67% Revenue and Profit Sales revenue year 2019 amounts to Baht 1,171.8 Million, Increased by 9.2 Million Baht or 0.8% compared to the previous year and

to decrease the policy rate 0.25% per year from 1.75% per year to 1.50% per year that is the first time in 4 years. However investment from inside and outside of Thailand will be increased from this

generated revenue of THB 1.2 million in this quarter, little increased by 2.1% when compared to the same period of prior year. 2. Revenue from services Revenue from services for this quarter was totally at

northern province, two Hemodialysis Center in eastern province and one Hemodialysis Center in central. So far the patients are continuously increasing and now the company continuously to focus on expanding

reckoned when compared to the revenue of Q1/2019. The reason behind this revenue direction may be from the expanding of COVID-19 outbreak, causing some businesses’ alarmed condition, delayed investment, or

from inside and outside of Thailand will be increased from this policy Retail business, Whole sale business, Restaurant and Hotel business will be increased and it will driving our Group's sale to